a developer of mechanism-targeted drugs to treat human cancers
Industry Biotechnology
A.I.dvisor tells us that CYCC and ONPPF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCC and ONPPF's prices will move in lockstep.
Ticker / NAME | Correlation To CYCC | 1D Price Change % | ||
---|---|---|---|---|
CYCC | 100% | -12.60% | ||
ONPPF - CYCC | 23% Poorly correlated | N/A | ||
GNPX - CYCC | 23% Poorly correlated | +2.50% | ||
BPTSY - CYCC | 21% Poorly correlated | N/A | ||
NGENF - CYCC | 21% Poorly correlated | -19.27% | ||
ATNF - CYCC | 21% Poorly correlated | -7.27% | ||
More |
Ticker / NAME | Correlation To CYCC | 1D Price Change % |
---|---|---|
CYCC | 100% | -12.60% |
biotechnology theme (238 stocks) | 9% Poorly correlated | -4.32% |
cancer theme (82 stocks) | 4% Poorly correlated | -5.37% |
drugs theme (254 stocks) | 2% Poorly correlated | -4.03% |
mechanical theme (6 stocks) | -6% Poorly correlated | -1.70% |